Indeed, intravenous administration of [Pyr1] apelin-13, an active fragment of apelin, in heart failure patients showed efficacy with peripheral and coronary vasodilatation and increases in cardiac output (Japp et al., 2010). The gene discussed is APLN; the disease is heart failure.